Awesome summary of efforts in advancement of gene editing by @theeconomist @natashaloder - @VertexPharma @BeamTx @PrimeMedicine @VerveTx & @AeraTx all pushing the landscape forward https://t.co/fNVWrMeeAS

The Economist@TheEconomist

2 years ago

Gene-editing treatments are marvels of innovation. But we argue that their pricing must be inventive, too https://t.co/y0ncUDLsWy 👇

“Gene editing is moving so fast that it seems only a question of when, not if, these new medicines will overcome their difficulties.” https://t.co/uBonRqMVjA